In addition, we evaluated the association between the risk for glioma and pre-diagnostic serum levels of EGFR and ErbB2 using both dichotomized and continuous protein abundance data to understand if chronic activation and high levels of the receptors could be a mechanism in gliomagenesis. The gene discussed is ERBB2; the disease is central nervous system cancer.